Intoxication volontaire par l’aldicarbe dans les Hauts de France : une situation sanitaire qui reste préoccupante en 2024

Autor: Azzouz, R., Meguig, S., Gaulier, J.-M., Peucelle, D., Nisse, P.

Publikováno v: In Toxicologie Analytique et Clinique October 2024 36(3) Supplement:S75-S75

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Levodopa improved different motor symptoms in patients with Parkinson's disease by reducing the functional connectivity of specific thalamic subregions.

Autor: Liu, Wan^1,2 (AUTHOR), Shen, Yang^2,3 (AUTHOR), Zhong, Yuan^4,5 (AUTHOR), Sun, Yu^6,7 (AUTHOR), Yang, Jiaying⁸ (AUTHOR), Zhang, Wenbin⁹ (AUTHOR), Yan, Lei² (AUTHOR), Liu, Weiguo² (AUTHOR) wgliunbh@sina.com, Yu, Miao² (AUTHOR) nj‐ym‐1988‐0107@hotmail.com

Publikováno v: CNS Neuroscience & Therapeutics. Feb2024, Vol. 30 Issue 2, p1-10. 10p.

The Relationship between Gene SLC6A3 Variable Number of Tandem Repeat (VNTR) and Attention-Deficit / Hyperactivity Disorder.

Autor: Seymari, Abbas¹ abbasseymari@msc.guilan.ac.ir, Naseh, Ashkan¹, Rezaei, Sajjad¹, Salehi, Zivar², Kousha, Maryam³

Publikováno v: Iranian Journal of Psychiatry. Jan2024, Vol. 19 Issue 1, p99-106. 8p.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Autor: Moreau C; 1 Department of Movement Disorders and Neurology, Lille University, CHU Lille, Lille, France 2 INSERM U1171, Lille University, Lille, France., Meguig S; 3 Department of Molecular Biology and Pathology Centre, Lille University, CHU Lille, Lille, France., Corvol JC; 4 Sorbonne Universités, UPMC Univ Paris 06, and INSERM UMRS_1127 and CIC_1422, and CNRS UMR_7225, and AP-HP, and ICM, Hôpital Pitié-Salpêtrière, Département des Maladies du Système Nerveux, Paris, France., Labreuche J; 5 Department of Biostatistics, Lille University, CHU Lille, Lille, France., Vasseur F; 5 Department of Biostatistics, Lille University, CHU Lille, Lille, France., Duhamel A; 5 Department of Biostatistics, Lille University, CHU Lille, Lille, France., Delval A; 1 Department of Movement Disorders and Neurology, Lille University, CHU Lille, Lille, France 2 INSERM U1171, Lille University, Lille, France., Bardyn T; 3 Department of Molecular Biology and Pathology Centre, Lille University, CHU Lille, Lille, France., Devedjian JC; 2 INSERM U1171, Lille University, Lille, France., Rouaix N; 3 Department of Molecular Biology and Pathology Centre, Lille University, CHU Lille, Lille, France., Petyt G; 6 Department of Nuclear Medicine, Lille University, CHU Lille, Lille, France., Brefel-Courbon C; 7 Departments of Clinical Pharmacology and Neurosciences, CIC9302, University Hospital and Paul Sabatier University, Toulouse, France., Ory-Magne F; 7 Departments of Clinical Pharmacology and Neurosciences, CIC9302, University Hospital and Paul Sabatier University, Toulouse, France., Guehl D; 8 Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR CNRS 5293 and CHU de Bordeaux, Bordeaux, France., Eusebio A; 9 Department of Neurology and Movement Disorders - APHM Timone University Hospital and Institut de Neurosciences de la Timone, AMU-CNRS UMR 7289, Marseille, France., Fraix V; 10 Department of Psychiatry and Neurology, CHU Grenoble, Grenoble, France., Saulnier PJ; 11 Department of Movement Disorders and Neurology, Centre d'Investigation Clinique, INSERM CIC 0802, INSERM U1084, Laboratoire de Neurosciences Expérimentales et Cliniques, CHU de Poitiers, Poitiers, France., Lagha-Boukbiza O; 12 Department of Movement Disorders and Neurology, CHU Strasbourg, Strasbourg, France., Durif F; 13 Department of Movement Disorders and Neurology, CHU Clermont-Ferrand, Clermont-Ferrand, France., Faighel M; 14 Department of Movement Disorders and Neurology, INSERM, CIC04, CHU Nantes, Nantes, France., Giordana C; 15 Department of Movement Disorders and Neurology, CHU Nice, Nice, France., Drapier S; 16 Department of Neurology, EA- 425 Université Rennes 1 et CHU Pontchaillou, CHU Rennes, Rennes, France., Maltête D; 17 Department of Neurology and INSERM CIC-CRB 0204, Rouen University Hospital, CHU Rouen Rouen, France., Tranchant C; 12 Department of Movement Disorders and Neurology, CHU Strasbourg, Strasbourg, France., Houeto JL; 11 Department of Movement Disorders and Neurology, Centre d'Investigation Clinique, INSERM CIC 0802, INSERM U1084, Laboratoire de Neurosciences Expérimentales et Cliniques, CHU de Poitiers, Poitiers, France., Debû B; 10 Department of Psychiatry and Neurology, CHU Grenoble, Grenoble, France., Azulay JP; 9 Department of Neurology and Movement Disorders - APHM Timone University Hospital and Institut de Neurosciences de la Timone, AMU-CNRS UMR 7289, Marseille, France., Tison F; 8 Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR CNRS 5293 and CHU de Bordeaux, Bordeaux, France., Destée A; 1 Department of Movement Disorders and Neurology, Lille University, CHU Lille, Lille, France 18 INSERM U837/6 Lille JPARC, France., Vidailhet M; 6 Department of Nuclear Medicine, Lille University, CHU Lille, Lille, France., Rascol O; 7 Departments of Clinical Pharmacology and Neurosciences, CIC9302, University Hospital and Paul Sabatier University, Toulouse, France 19 INSERM NS-PARK National Network, France., Dujardin K; 1 Department of Movement Disorders and Neurology, Lille University, CHU Lille, Lille, France 2 INSERM U1171, Lille University, Lille, France., Defebvre L; 1 Department of Movement Disorders and Neurology, Lille University, CHU Lille, Lille, France 2 INSERM U1171, Lille University, Lille, France., Bordet R; 2 INSERM U1171, Lille University, Lille, France 18 INSERM U837/6 Lille JPARC, France., Sablonnière B; 3 Department of Molecular Biology and Pathology Centre, Lille University, CHU Lille, Lille, France., Devos D; 1 Department of Movement Disorders and Neurology, Lille University, CHU Lille, Lille, France 2 INSERM U1171, Lille University, Lille, France 20 Department of Medical Pharmacology, Lille University, CHU Lille, Lille, France david.devos@chru-lille.fr.

Publikováno v: Brain : a journal of neurology [Brain] 2015 May; Vol. 138 (Pt 5), pp. 1271-83. Date of Electronic Publication: 2015 Mar 23.